Scientists dispute a suggestion that SARS-CoV-2 was engineered

Belgique Nouvelles Nouvelles

Scientists dispute a suggestion that SARS-CoV-2 was engineered
Belgique Dernières Nouvelles,Belgique Actualités
  • 📰 TheEconomist
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 92%

On October 20th an un-peer-reviewed “preprint” was published, claiming to show that SARS-COV-2 is the product of genetic engineering. Other researchers are now weighing in with criticisms

In the past few days, scrutiny has intensified, and doubts are starting to accumulate. Justin Kinney, a professor of quantitative biology at Cold Spring Harbor Laboratory, in New York, has taken a closer look at the preprint and says the work is intriguing but some important questions need to be dealt with before it could be said to be convincing. One is the likelihood that researchers would decide to keep the restriction sites in the genome.

The toughest challenges of all, though, are observations by people such as Edward Holmes, an evolutionary biologist and virologist at the University of Sydney, that the restriction sites pointed out in the preprint are found naturally in bat coronaviruses closely related to

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

TheEconomist /  🏆 6. in UK

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Is vaccine status associated with the severity of Omicron SARS-CoV-2 infection in hospitalized patients?Is vaccine status associated with the severity of Omicron SARS-CoV-2 infection in hospitalized patients?Is vaccine status associated with the severity of Omicron SARS-CoV-2 infection in hospitalized patients? medrxivpreprint Omicron SARSCoV2 infection COVID19 coronavirus covid vaccine vaccination
Lire la suite »

Scientists computationally restore the potency of an antibody against SARS-CoV-2 Omicron subvariantsScientists computationally restore the potency of an antibody against SARS-CoV-2 Omicron subvariantsA team of researchers from the United States computationally modified the COV2-2130 monoclonal antibody to restore its neutralizing ability against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants, while retaining efficacy against the Delta and wild-type strains.
Lire la suite »

The effectiveness of BNT162b2 COVID-19 vaccine against infection with SARS-CoV-2 Omicron subvariants BA.4/5The effectiveness of BNT162b2 COVID-19 vaccine against infection with SARS-CoV-2 Omicron subvariants BA.4/5The effectiveness of BNT162b2 COVID-19 vaccine against infection with SARS-CoV-2 Omicron subvariants BA.4/5 TheLancetInfDis COVID19 coronavirus covid vaccine vaccination Omicron infection
Lire la suite »

Increased Gibbs energy of binding indicates greater infectivity of SARS-CoV-2 BA.2.75Increased Gibbs energy of binding indicates greater infectivity of SARS-CoV-2 BA.2.75Increased Gibbs energy of binding indicates greater infectivity of SARS-CoV-2 BA.2.75 Coronavirus Disease COVID SARSCoV2 MDPIOpenAccess TU_Muenchen
Lire la suite »



Render Time: 2025-03-24 00:26:31